NEO100 and High-Grade Meningioma
NEO100 and High-Grade Meningioma
Recruiting · NCT05023018 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NEO100 and High-Grade Meningioma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-09-15 | NCT05023018 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Neonc Technologies, Inc. | 4 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor Scott and White | Dallas | United States | 6 |
| Saint John Cancer Institute | Santa Monica | United States | 2 |
| Sutter Health Research Institute | San Francisco | United States | 2 |
| Tufts Medical Center | Boston | United States | 238 |
| University of Southern California | Los Angeles | United States | 110 |